CELG News 171.42 06/25/2014 04:34:39 Celgene Corp (CELG)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Celgene Corp (CELG) 171.42 $CELG

'Fast Money' Recap: A Mixed Bag for Housing
at The Street - 34 mins ago
The trading panel discussed the stock market's big drop, how low the S&P can go and why bonds aren't selling off.

Final Glance: Biotechnology companies
AP - Tue Jun 24, 5:04PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:

Midday Glance: Biotechnology companies
AP - Tue Jun 24, 12:17PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 1 p.m.:

Early Glance: Biotechnology companies
AP - Tue Jun 24, 9:52AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 10 a.m.:

Celgene, Chipotle, Keurig Remain In Buying Range
at Investor's Business Daily - Mon Jun 23, 6:52PM CDT
This week's Big Cap 20 list showed a few changes from last week, as Apple (AAPL), Encana (ECA) and Magna International (MGA) fell out and were replaced by Celgene (CELG), Spectra Energy (SE) and Southwest Airlines (LUV) . Energy plays still dominate...

Stocks Poised For Soft Start; Micros Systems Surges Premarket
at Investor's Business Daily - Mon Jun 23, 7:56AM CDT
The stock market today appeared poised for a mildly lower start despite upbeat Chinese factory data and a round of deal news. Nasdaq 100 futures fell 2 points vs. fair value, while S&P 500 futures edged down less than 1 point. Dow futures lost 12...

Celgene Sees Better Results For Psoriatic Arthritis
at Investor's Business Daily - Fri Jun 20, 5:12PM CDT
When a large biotechnology company has a wonder drug, it makes sense to see if the product can treat multiple diseases. Celgene (CELG) has done well in this regard. In January, Celgene's key drug Abraxane won approval in Europe for use in combination...

Stocks Hold Slim Gains; Celgene, Salix Rally
at Investor's Business Daily - Fri Jun 20, 2:02PM CDT
The major stock indexes continued to trade modestly higher late Friday and were on pace to end the week with gains of more than 1%. The Dow Jones industrial average rose 0.2%. The broader Nasdaq and the S&P 500 edged up 0.1% each. Amid quadruple...

Celgene (CELG) Approaches New Upside Target of $171.95
Comtex SmarTrend(R) - Fri Jun 20, 12:28PM CDT
Celgene (NASDAQ:CELG) has opened bullishly above the pivot of $166.67 today and has reached the first level of resistance at $170.13. Investors may be interested in a cross of the next upside pivot targets of $171.95 and $177.23.

Celgene Rises on Yet Another Stock Split - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 10:30AM CDT
Shares of Gelgene (CELG) gained following the approval of a stock split.

Shares of CELG Up 12.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Jun 20, 9:33AM CDT
SmarTrend identified an Uptrend for Celgene (NASDAQ:CELG) on May 1st, 2014 at $147.87. In approximately 2 months, Celgene has returned 12.94% as of today's recent price of $167.00.

Company News for June 20, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 9:06AM CDT
Companies in the News are: BBRY,RAD,CELG,KR

Celgene's stockholders authorises two-for-one common stock split
M2 - Fri Jun 20, 5:39AM CDT
Biopharmaceutical company Celgene (NasdaqGS:CELG) said on Thursday that its stockholders have approved a two-for-one stock split of its common stock at its Annual Meeting of Stockholders held on 18 June 2014.

'Mad Money' Lightning Round: Buy, Buy, Buy Stryker
at The Street - Fri Jun 20, 5:00AM CDT
Cramer prefers Celgene over Gilead Sciences, Palo Alto Networks over OSI Systems and is discouraged by IBM.

'Fast Money' Recap: Late-Day Rally, Another Record High
at The Street - Fri Jun 20, 4:00AM CDT
The trading panel looked at gold and oil as the S&P hit another record high.

Jim Cramer's 'Mad Money' Recap: Management Matters, Not the Fed
at The Street - Thu Jun 19, 6:57PM CDT
People obsessed with the Fed have kept you out of the market, Cramer said, and the Fed's bond buyback tapering is simply not having an impact.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Perigon Builds Its Investment Bench for the Next Leg

Updated Category News Views 129

Perigon is rearranging the engine room before the next growth spurt gets noisy. The firm has named Christopher Broderick Director of Investments and Research, added two trading associates, and put another brick behind the broader operating structure Rafia Hasan has been assembling since taking on the chief operating officer role in August. That may sound like ordinary...

Continue Reading
Teachstone’s Bronze Award Puts Classroom Quality in Focus

Updated Category News Views 36

Small Classroom Moments Finally Get Their Due A child’s hesitant question can disappear in the noise of a busy classroom, which is precisely why Teachstone’s latest recognition deserves more than the usual polite golf clap. The Charlottesville-based Certified B Corporation received a Bronze Anthem Award for its “From Measurement to Momentum” initiative, in the...

Continue Reading
Sleep Number’s Couples Pitch Has Some Fine Print Too

Updated Category News Views 75

A thermostat war in the bedroom is a lousy reason to buy the wrong mattress. Yet that is the mundane, very real problem Sleep Number is leaning into after Expert Consumers named it a leading 2026 choice for couples seeking personalized sleep comfort. The company’s argument is straightforward: two people sharing a bed should not have to share one firmness setting, or...

Continue Reading
CASEKOO's Montana Story Makes Brand Purpose Personal

Updated Category News Views 45

A blurry Montana kitchen, not a glossy product render, is doing the heavy lifting for CASEKOO this Thanksgiving. That is either a smart bit of brand discipline or a sentimental detour, depending on whether the company can make people feel something without losing sight of why they bought a phone case in the first place. Warmth Takes the Place of Hardware CASEKOO's new...

Continue Reading
Pennsylvania Housing Finds Its October Holding Pattern

Updated Category News Views 100

Pennsylvania's October housing numbers have the uneasy stillness of a pond before somebody throws a rock. The statewide median sales price sat at $315,000, exactly where it was in September, while sales barely cleared 10,400 and available listings kept inching higher. Nothing in that mix screams boom or bust. Frankly, that is the point: a market can look calm on the...

Continue Reading
U.S. Employers Signal a Deeper Multilingual Skills Gap

Updated Category News Views 90

A language gap rarely makes the loudest noise in an earnings call, yet it can quietly wreck a sales effort, a hiring plan, or a customer relationship. ACTFL's updated 2026 employer study puts some hard edges around that problem: U.S. businesses say multilingual capability is not a nice cultural accessory. It is increasingly part of operating the business. Demand Has Moved...

Continue Reading
Childhood Nutrition Advice That Lowers Mealtime Stress

Updated Category News Views 72

A toddler surviving on three bites Tuesday is not a verdict on the family table. That plain idea sits at the center of pediatric expert Kathy Shirazi’s guidance on childhood nutrition, and frankly, it deserves more oxygen than another impossible-looking lunchbox photo. In the HelloNation article released November 20, 2026, Shirazi, MD, MPH, FAAP, urges parents to judge...

Continue Reading
North Richland Hills Bets on Its Visitor Momentum Now

Updated Category News Views 65

A crowded family attraction map is a nice problem for a Texas city to have, and North Richland Hills is trying to turn that pile of assets into a cleaner regional tourism machine. On Nov. 20, 2026, the city introduced “The Place You Never Outgrow,” its first destination-marketing campaign, built with Flat Five Marketing. This is not a stock story in the usual...

Continue Reading
Digital Diabetes Care Has a Bigger Prize Than Devices

Updated Category News Views 121

A glucose sensor is becoming less a gadget than a running conversation between patient, clinician and software. That shift matters because diabetes management is leaving the occasional clinic visit and moving into daily life, where the useful product is not merely a reading but a pattern someone can act on. The sector deserves attention from investors, but it also...

Continue Reading
S&P Global's UBS AI Conference Slot Deserves Attention

Updated Category News Views 88

Thirty Minutes Can Still Matter A half-hour fireside chat is not a quarterly earnings call, and anybody treating it like one is setting themselves up for disappointment. Still, S&P Global CEO Martina Cheung appearing at the UBS Global Technology and AI Conference on December 2 deserves a spot on the calendar for owners of NYSE:SPGI. This is a company sitting in the middle...

Continue Reading

Top 5 Most Recently Viewed Articles

Specialty1 Partners Drives New Growth Through Partnerships

Updated Category News Views 227

Specialty1 Partners Fuels Growth with Innovative Model Specialty1 Partners (S1P) has emerged as a leader in the specialty dental partnership sector, focusing on aiding Endodontists, Periodontists, and Oral Surgeons in elevating their practices. Their innovative joint venture model is increasingly attracting dental specialists eager to transition from associates to...

Continue Reading
Union Pacific in Talks for Major Norfolk Southern Merger

Updated Category News Views 263

Union Pacific's Ambitious Merger Talks Union Pacific Corp. (NYSE: UNP) is reportedly engaged in preliminary discussions to acquire Norfolk Southern Corp. (NYSE: NSC), marking a prospective mega-merger in the railroad industry. While details are still emerging, the implications of such a merger could significantly reshape the freight transport landscape across the United...

Continue Reading
Great Elm Capital Corp.'s Impressive Second Quarter Performance

Updated Category News Views 147

Overview of Financial Achievements Great Elm Capital Corp. (NASDAQ: GECC) has recently released its financial performance report for the second quarter, demonstrating remarkable growth and a prosperous quarter for the company. This update is essential for investors and stakeholders keen on understanding the company's current financial health and future prospects. Record...

Continue Reading
Scandinavian Tobacco Group Updates on Share Buy-back Activities

Updated Category News Views 211

Scandinavian Tobacco Group A/S launched a significant share buy-back program back in November, worth up to DKK 850 million. The move aimed at adjusting the company's capital structure and meeting obligations tied to its share-based incentive programs. This isn’t just a random act; it’s a strategic ploy in a competitive market that’s meant to bolster their stock...

Continue Reading
Breakthrough Outcomes of Telitacicept in Sjögren's Syndrome Study

Updated Category News Views 220

Exciting Developments in Telitacicept Phase III Trial Results The Phase III clinical trial results for Telitacicept are sparking significant interest, particularly within the realm of Sjögren's Syndrome. This autoimmune condition can severely affect patients' quality of life due to symptoms like dry mouth and dry eyes, among others. Recently, announcements surrounding...

Continue Reading